A Submicron Lipid Emulsion Coated with Amphipathic Polyethylene Glycol for Parenteral Administration of Paclitaxel (Taxol)
Author:
Open Access
- 1 January 1997
- journal article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 49 (1) , 16-21
Abstract
Paclitaxel is a promising anticancer agent with poor solubility in water and requires a suitable formulation for intravenous administration. Presently paclitaxel is formulated for clinical use in ethanol and Cremophor EL (Diluent 12), a solvent system associated with severe adverse effects. In this study paclitaxel was entrapped in lipid emulsion droplets with triolein as oil core and dipalmitoyl phosphatidylcholine as the principal emulsifier. The emulsion was further stabilized with polysorbate 80 and polyethylene glycol-dipalmitoyl phosphatidy-lethanolamine. The drug-emulsion droplets (diameter about 40 nm) were physically and chemically stable during several months at 4°C. Lyophilized preparations in 5% glucose were completely restored by distilled water. Studies of the integrity of the drug-emulsion showed a release of the drug from emulsion globules and surface transfer was found to be the major mechanism for cellular uptake. The in-vitro antiproliferative activity of paclitaxel against T-47D cells was retained by the drug-emulsion with an ID50 value of 7 nM compared to 10 and 35 nM for paclitaxel in liposomes and Diluent 12, respectively. Long-circulating submicron lipid emulsions may prove useful, not only for replacement of the more toxic Cremophor EL vehicle, but also by improving the distribution of the drug to the tumour.Keywords
This publication has 26 references indexed in Scilit:
- Submicron lipid emulsions containing amphipathic polyethylene glycol for use as drug-carriers with prolonged circulation timeInternational Journal of Pharmaceutics, 1996
- Solvent- and Concentration-Dependent Molecular Interactions of Taxol (Paclitaxel †)Journal of Pharmaceutical Sciences, 1994
- Differential cytotoxic effects of docetaxel in a range of mammalian tumor cell lines and certain drug resistant sublinesin vitroInvestigational New Drugs, 1994
- Taxol-Lipid Interactions: Taxol-Dependent Effects on the Physical Properties of Model MembranesBiochemistry, 1994
- A Mixed Micellar Formulation Suitable for the Parenteral Administration of TaxolPharmaceutical Research, 1994
- Preparation of Drug-Carrier Emulsions Stabilized with Phosphatidylcholine-Surfactant MixturesJournal of Pharmaceutical Sciences, 1994
- Cytotoxic studies of paclitaxel (Taxol®) in human tumour cell linesBritish Journal of Cancer, 1993
- Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast CancerJNCI: Journal of the National Cancer Institute, 1991
- Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivoBiochimica et Biophysica Acta (BBA) - Biomembranes, 1991
- Delivery of Novel Therapeutic Agents in Tumors: Physiological Barriers and StrategiesJNCI: Journal of the National Cancer Institute, 1989